- Home
- JAGU vs YI Comparison
JAGU vs YI Comparison
Compare JAGU & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JAGU | YI |
|---|---|---|
| Founded | 2022 | 2010 |
| Country | Canada | China |
| Employees | 3 | N/A |
| Industry | | Retail-Drug Stores and Proprietary Stores |
| Sector | | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.9M | 46.4M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | JAGU | YI |
|---|---|---|
| Price | $1.93 | $4.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 83.8K | 22.5K |
| Earning Date | 03-27-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.44 | $2.48 |
| 52 Week High | $3.60 | $11.17 |
Technical Indicators
Market Signals| Indicator | JAGU | YI |
|---|---|---|
| Relative Strength Index (RSI) | 42.23 | 31.24 |
| Support Level | $1.52 | $4.31 |
| Resistance Level | $2.94 | $4.88 |
| Average True Range (ATR) | 0.24 | 0.51 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 43.92 | 11.70 |
Price Performance
Historical ComparisonAbout JAGU Jaguar Uranium Corp. Class A Common Shares
Jaguar Uranium Corp is a uranium exploration and development company focused on uranium discoveries. The company is a junior miner engaged in uranium exploration. Its portfolio is comprised of two uranium exploration projects in Argentina and one uranium exploration project in Colombia. Its projects include the Berlin Project, the Laguna Project, and the Huemul Project. The company operates in one reportable segment which is the exploration and evaluation of mineral properties.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.